Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

AUTLAUTL
7 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in AUTOLUS THERAPEUTICS LTD

BANK OF AMERICA CORP /DE/ holds 1.6M shares of AUTL (AUTOLUS THERAPEUTICS LTD), worth $2.6M as of 2026-Q2. The position was decreased (-13.0% shares). AUTL represents 0.0% of BANK OF AMERICA CORP /DE/'s portfolio.

Current Value

$2.6M

Current Shares

1.6M

Total Value Change

+$2.5M

Total Shares Change

+1.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.6M
-13.0%
$2.6M0.0%$1.60
0
2026-Q1
Decreased
1.8M
-5.9%
$2.5M0.0%$1.62
0
2025-Q4
Decreased
2M
-3.4%
$3.9M0.0%$1.97
0
2025-Q3
Increased
2M
+108.1%
$3.3M0.0%$1.59
43
2025-Q2
Increased
975,135
+2891.7%
$2.2M0.0%$2.31
42
2025-Q1
Decreased
32,595
-30.1%
$50,5220.0%$1.66
0
2024-Q4
New
46,598
-
$109,5060.0%$2.21
33

Other major holders of AUTL: Blackstone Inc., WELLINGTON MANAGEMENT GROUP LLP, Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used